169 related articles for article (PubMed ID: 16432913)
1. Stereoselective binding of human serum albumin.
Chuang VT; Otagiri M
Chirality; 2006 Feb; 18(3):159-66. PubMed ID: 16432913
[TBL] [Abstract][Full Text] [Related]
2. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis.
Simard JR; Zunszain PA; Hamilton JA; Curry S
J Mol Biol; 2006 Aug; 361(2):336-51. PubMed ID: 16844140
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective irreversible binding of ketoprofen glucuronides to albumin. Characterization of the site and the mechanism.
Presle N; Lapicque F; Fournel-Gigleux S; Magdalou J; Netter P
Drug Metab Dispos; 1996 Oct; 24(10):1050-7. PubMed ID: 8894504
[TBL] [Abstract][Full Text] [Related]
4. Species-dependent stereoselective drug binding to albumin: a circular dichroism study.
Pistolozzi M; Bertucci C
Chirality; 2008 Mar; 20(3-4):552-8. PubMed ID: 18172833
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of stereoselective serum binding of ketoprofen after hemodialysis.
Sakai T; Maruyama T; Imamura H; Shimada H; Otagiri M
J Pharmacol Exp Ther; 1996 Aug; 278(2):786-92. PubMed ID: 8768732
[TBL] [Abstract][Full Text] [Related]
6. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin.
Bhattacharya AA; Grüne T; Curry S
J Mol Biol; 2000 Nov; 303(5):721-32. PubMed ID: 11061971
[TBL] [Abstract][Full Text] [Related]
7. In vitro binding of leukotriene B4 (LTB4) to human serum albumin: evidence from spectroscopic, molecular modeling, and competitive displacement studies.
Zsila F; Bikádi Z; Lockwood SF
Bioorg Med Chem Lett; 2005 Aug; 15(16):3725-31. PubMed ID: 15993588
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective binding of etodolac to human serum albumin.
Muller N; Lapicque F; Monot C; Payan E; Dropsy R; Netter P
Chirality; 1992; 4(4):240-6. PubMed ID: 1389961
[TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics study of conformational changes in human serum albumin by binding of fatty acids.
Fujiwara S; Amisaki T
Proteins; 2006 Aug; 64(3):730-9. PubMed ID: 16783783
[TBL] [Abstract][Full Text] [Related]
10. Evidence that the principal CoII-binding site in human serum albumin is not at the N-terminus: implication on the albumin cobalt binding test for detecting myocardial ischemia.
Mothes E; Faller P
Biochemistry; 2007 Feb; 46(8):2267-74. PubMed ID: 17274600
[TBL] [Abstract][Full Text] [Related]
11. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
[TBL] [Abstract][Full Text] [Related]
12. Stereoselectivity and enantiomer-enantiomer interactions in the binding of ibuprofen to human serum albumin.
Itoh T; Saura Y; Tsuda Y; Yamada H
Chirality; 1997; 9(7):643-9. PubMed ID: 9366025
[TBL] [Abstract][Full Text] [Related]
13. Chain length-dependent binding of fatty acid anions to human serum albumin studied by site-directed mutagenesis.
Kragh-Hansen U; Watanabe H; Nakajou K; Iwao Y; Otagiri M
J Mol Biol; 2006 Oct; 363(3):702-12. PubMed ID: 16979183
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective protein binding of ketoprofen: effect of albumin concentration and of the biological system.
Dubois N; Lapicque F; Abiteboul M; Netter P
Chirality; 1993; 5(3):126-34. PubMed ID: 8338722
[TBL] [Abstract][Full Text] [Related]
15. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
Nishio T; Takamura N; Nishii R; Tokunaga J; Yoshimoto M; Kawai K
Nephrol Dial Transplant; 2008 Jul; 23(7):2304-10. PubMed ID: 18390890
[TBL] [Abstract][Full Text] [Related]
16. Study of interaction between drug enantiomers and serum albumin by capillary electrophoresis.
Ding Y; Zhu X; Lin B
Electrophoresis; 1999 Jul; 20(9):1890-4. PubMed ID: 10445331
[TBL] [Abstract][Full Text] [Related]
17. Analysis of binding interaction between the natural apocarotenoid bixin and human serum albumin by circular dichroism and fluorescence spectroscopy.
Zsila F; Molnár P; Deli J
Chem Biodivers; 2005 Jun; 2(6):758-72. PubMed ID: 17192019
[TBL] [Abstract][Full Text] [Related]
18. A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions.
Buttar D; Colclough N; Gerhardt S; MacFaul PA; Phillips SD; Plowright A; Whittamore P; Tam K; Maskos K; Steinbacher S; Steuber H
Bioorg Med Chem; 2010 Nov; 18(21):7486-96. PubMed ID: 20869876
[TBL] [Abstract][Full Text] [Related]
19. Structural basis of the drug-binding specificity of human serum albumin.
Ghuman J; Zunszain PA; Petitpas I; Bhattacharya AA; Otagiri M; Curry S
J Mol Biol; 2005 Oct; 353(1):38-52. PubMed ID: 16169013
[TBL] [Abstract][Full Text] [Related]
20. In vitro stereoselective degradation of carprofen glucuronide by human serum albumin. Characterization of sites and reactive amino acids.
Georges H; Presle N; Buronfosse T; Fournel-Gigleux S; Netter P; Magdalou J; Lapicque F
Chirality; 2000 Feb; 12(2):53-62. PubMed ID: 10637410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
